Hair Loss on Testosterone Therapy Is Not Really About Testosterone

The hair loss some men worry about when considering testosterone therapy is not, strictly speaking, a question about testosterone.

It is a question about DHT, and the distinction is worth drawing properly, because almost everything that follows in this conversation depends on it.

Here is what is actually happening, what the available options are, and why the popular assumption about one of them does not hold.

What Is DHT, and What Does It Have to Do With Hair?

The body converts some testosterone into DHT.

DHT is the hormone that acts on hair follicles in male pattern baldness. That is a different statement from saying testosterone causes hair loss, and the difference is not a technicality — it is the reason the available approaches target the conversion rather than the testosterone.

The conversion itself is a normal process rather than a malfunction. It is not something that has gone wrong.

What Does Finasteride Do?

It blocks that conversion.

That is the whole mechanism in one sentence, and it explains why the medication exists at all in this context. Reduce the conversion, and less DHT is produced.

Finasteride is a prescription medication. Whether it is appropriate for anyone is a clinical determination, and nothing in this article should be read as a recommendation to take it.

What Forms Does It Come In?

It comes as a pill, and it is also compounded into topical forms applied to the scalp.

The topical version is the newer arrival in the conversation and the one generating most of the current discussion. The reasoning behind it is straightforward on its face: apply the medication where the effect is wanted, and less of it should end up elsewhere.

That reasoning is not wrong. It is just incomplete, and the gap is where people get into trouble.

Is Topical Automatically the Safer Choice?

A great many people assume so, and the assumption is understandable.

A randomized trial found that topical finasteride reached far lower levels in the bloodstream than the pill, and lowered circulating DHT less. Taken alone, that finding reads as a straightforward case for the topical version.

It is not that simple, and the reason is in the word "lower."

Why Is Less Exposure Not the Same as No Exposure?

Because finasteride applied to the skin is still absorbed.

Lower blood levels than the pill is a comparison. It is not a finding of absence, and it does not establish that a systemic effect has been removed rather than reduced.

The FDA has warned that compounded topical products have been linked to reports of the same side effects reported with the pill, and that those effects often persisted after men stopped using them. That is a warning about a real pattern of reports, and it is the part most often left out when the topical form is presented as the obvious answer.

Less exposure is not the same thing as no exposure. Someone choosing the topical form on the belief that it carries no systemic risk has made the decision on a premise that is not established.

Does This Mean Topical Finasteride Should Be Avoided?

That is not what any of the above says, and it is worth being careful in both directions.

A lower blood level is a real difference, and for some people it may be a relevant one. A warning about reported side effects is not a finding that those effects are common, and it is not a prediction about any individual.

What the picture supports is a decision made with the full set of facts rather than with only the reassuring half. Both halves are in this article deliberately.

What Decides Whether Finasteride Fits at All?

Your laboratory results, your symptoms and your health history.

Which form fits, whether either form fits, and whether the subject belongs in your treatment plan at all are clinical determinations. They depend on individual factors that cannot be assessed from a description of how the medication works.

If hair loss is one of the reasons you are interested in a hormone evaluation, that is worth naming at the appointment rather than leaving unsaid. An unstated concern cannot be addressed, and a licensed provider has heard the question before.

The Bottom Line

1. The hair loss concern is about DHT rather than testosterone directly. The body converts some testosterone into DHT, and DHT is the hormone acting on hair follicles in male pattern baldness.
2. Finasteride blocks that conversion. It comes as a pill and is also compounded into topical forms applied to the scalp.
3. A randomized trial found topical finasteride reached far lower levels in the bloodstream than the pill, and lowered circulating DHT less.
4. Finasteride on the skin is still absorbed. The FDA has warned that compounded topical products have been linked to reports of the same side effects reported with the pill, often persisting after men stopped.
5. Less exposure is not no exposure, and which form fits, or whether finasteride fits at all, depends on your labs, your symptoms and your health history.

The reassuring half of this story is true. So is the other half, and a decision made on one of them is a decision made on half the information.